Why the study?
Cardiac myofibrillary dysfunction represents an early subclinical manifestation of heart failure, and this study explored whether epicardial adipose tissue affects early myocardial dysfunction assessed by strain values.
Is epicardial adipose tissue thickness related to early subclinical myocardial dysfunction in patients with and without type 2 diabetes mellitus?
Is epicardial adipose tissue thickness related to early subclinical myocardial dysfunction in patients with and without type 2 diabetes mellitus?
Epicardial adipose tissue thickness correlates with early subclinical myocardial dysfunction measured by echocardiographic strain, particularly in patients with type 2 diabetes.
Should not yet change practice in patients without HF; leaves open a potential role for EAT in early diabetic cardiomyopathy.
BACKGROUND: Cardiac myofibrillary dysfunction, which can be measure by echocardiographical strain value, represents an early subclinical manifestation of heart failure. Epicardial Adipose tissue (EAT) is related to low degree inflammation and oxidative damage in the adjacent tissue. AIM: To explore whether EAT affects early myocardial dysfunction, as assessed strain values. METHODS: Case-Control design. Patients lacking clinical significant heart failure, thyroid or renal disease or malignant abnormalities were included. Clinical-demographic and biochemical data were collected. EAT and myofibril deformation were measured by echocardiography. RESULTS: A total of 71 patients were analyzed, and further subdivided according to type 2 Diabetes Mellitus (t2DM). Higher strain value (higher than -22.4%cut-off value) was associated with male sex and higher anthropometric and metabolic risk measures; particularly those with t2DM. Higher EAT was also associated higher strain value (AUC = 0.92 ± 0.06, p = 0.004), and further correlation was evidenced (rho = 0.488, p < 0.001), with significant influence of t2DM. CONCLUSION: EAT was related to strain value, suggesting the influence of cardiac adipose tissue on the deformability of cardiac myofibril, with a more significant effect in the population with t2DM.
No takes yet. Share an insight, caveat, or question.
Prestegui-Muñóz et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: